Back
Day Range
$3.37
$3.57
52-Week Range
$1.15
$6.75
Volume
5,301,410
50D / 200D Avg
$3.80
/
$4.04
Prev Close
$3.49
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.3 | 0.4 |
| P/B | 5.5 | 2.9 |
| ROE % | -83.1 | 3.7 |
| Net Margin % | -48464.0 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.2 | 0.2 |
Key Takeaways
Debt/Equity of 0.21 — conservative balance sheet
Negative free cash flow of -82.53M
Capital intensive — 30.84% of revenue goes to capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-1.91%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-83.10%
ROIC-54.62%
Net Margin-48463.96%
Op. Margin-33341.23%
Safety
Debt / Equity
0.21
Current Ratio3.21
Interest Coverage-32.87
Valuation
P/E Ratio
-4.28
P/B Ratio5.50
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.91% | Revenue Growth (3Y) | 14.97% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 308,000.0 | Net Income (TTM) | -149.27M |
| ROE | -83.10% | ROA | -93.65% |
| Gross Margin | 100.00% | Operating Margin | -33341.23% |
| Net Margin | -48463.96% | Free Cash Flow (TTM) | -82.53M |
| ROIC | -54.62% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.21 | Current Ratio | 3.21 |
| Interest Coverage | -32.87 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4.28 | P/B Ratio | 5.50 |
| P/S Ratio | 2076.10 | PEG Ratio | -0.01 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 639.44M | Enterprise Value | 646.64M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 308,000.0 | 314,000.0 | 233,000.0 | 20.38M | 0.0 |
| Net Income | -149.27M | -40.22M | -152.39M | -167.81M | -169.84M |
| EPS (Diluted) | -0.93 | -0.25 | -0.91 | -0.83 | -0.67 |
| Gross Profit | 308,000.0 | 314,000.0 | 233,000.0 | 20.38M | 0.0 |
| Operating Income | -102.69M | -125.47M | -144.79M | -135.81M | -104.16M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 159.39M | 293.48M | 305.44M | 414.17M | 111.55M |
| Total Liabilities | 42.83M | 49.16M | 39.68M | 28.21M | 16.18M |
| Shareholders' Equity | 116.30M | 242.96M | 260.74M | 376.91M | 90.82M |
| Total Debt | 24.71M | 19.14M | 15.34M | 743,000.0 | 2.18M |
| Cash & Equivalents | 17.51M | 45.03M | 190.61M | 362.27M | 97.25M |
| Current Assets | 80.13M | 185.59M | 287.15M | 375.08M | 99.55M |
| Current Liabilities | 24.95M | 20.12M | 19.90M | 20.94M | 12.30M |